阿迪波金作为临床相关的治疗目标在肥胖症
Marleen Würfel1, Matthias Blüher1,2, Michael Stumvoll1
1Department of Medicine III, Division of Endocrinology, Nephrology and Rheumatology, University of Leipzig, Liebigstr. 18, 04103 Leipzig, Germany.
Biomedicines
|May 27, 2023
概括
脂肪组织中的蛋白质阿迪波金是肥胖和代谢障碍的关键. 某些阿迪波金如FGF19,FGF21和瘦素在治疗肥胖和相关疾病方面表现有前途.
科学领域:
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
- 肥胖科学科学 肥胖科学
背景情况:
- 阿迪波金在肥胖的发展中起着至关重要的作用,并将脂肪组织功能障碍与代谢和心血管问题联系起来.
- 虽然许多阿迪波金的功能已知,但调节途径尚不清楚,临床转化仍然有限.
- 阿迪波金具有作为肥胖和相关代谢障碍的生物标志物和治疗点的巨大潜力.
研究的目的:
- 审查adipokines在诊断和治疗肥胖和相关代谢障碍方面的临床实用性.
- 以实验研究为基础,介绍一下具有临床应用潜力的阿迪波金的概述.
- 突出针对肥胖和并发性疾病具有有前途的治疗潜力的特定阿迪波金.
主要方法:
- 对阿迪波金治疗肥胖的诊断和治疗策略的临床研究进行系统审查.
- 对实验数据的分析,以确定各种阿迪波金的潜在临床应用.
- 专注于纤维细胞生长因子 (FGFs) 和瘦素治疗肥胖.
主要成果:
- 纤维细胞生长因子 (FGF) -19,FGF-21和瘦素显示出在肥胖治疗中临床应用的巨大潜力.
- 阿迪波涅克丁,瓦斯宾,抵抗素,化学素,维斯法丁,骨形态遗传蛋白7 (BMP-7) 和瘤亡因子α (TNF-α) 也显示出人类临床使用的潜力.
- 该审查巩固了阿迪波金作为诊断生物标志物和治疗剂的证据.
结论:
- 阿迪波金在肥胖和代谢疾病的发病过程中至关重要,提供治疗机会.
- 对于肥胖和相关疾病的未来临床应用,FGF-19,FGF-21和瘦素特别有希望.
- 需要进一步的研究和临床试验,才能充分实现各种阿迪波金的诊断和治疗潜力.
相关概念视频
Obesity
552
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
552
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Regulation of Food Intake
290
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
290
Glucagon-like Receptor Agonists
372
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
372
Hypodermis
4.7K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
4.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


